Abstract
Question: A 20-year-old male college student with a history of Crohn’s disease was noted to have pancytopenia on routine lab monitoring. He was diagnosed with stricturing Crohn’s disease of the terminal ileum and colon over 10 years ago when he presented with weight loss and bloody diarrhea. He struggled with perianal fistulizing disease periodically. His Montreal classification was A1 L3 B2p. Previous therapies included corticosteroids, mesalamine, azathioprine, 6-MP, infliximab, adalimumab, methotrexate, and certolizumab often in combination.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
